Potential role of the gut/liver/lung axis in alcohol-induced tissue pathology

Biomolecules

Volumn 5, Issue 4, 2015, Pages 2477-2503

  Massey, Veronica L ^a   Beier, Juliane I ^a   Ritzenthaler, Jeffrey D ^a   Roman, Jesse ^a   Arteel, Gavin E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Ethanol; Extracellular matrix; Hepatic; Inflammation; Pulmonary

Indexed keywords

ALCOHOL ABSTINENCE; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ALCOHOL USE DISORDER; DOWN REGULATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIVER INJURY; LUNG INJURY; NONHUMAN; OXIDATIVE STRESS; REVIEW; TISSUE INJURY; ACUTE LUNG INJURY; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ALCOHOL;

ACUTE LUNG INJURY; ANIMALS; ETHANOL; EXTRACELLULAR MATRIX; HUMANS; LIVER; LIVER DISEASES, ALCOHOLIC; OXIDATIVE STRESS;

EID: 85012039847     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5042477     Document Type: Review

References (161)

1. U.S. Department of Health and Human Services. Results from the 2010 National Survey on Drug Use and Health; U.S. Department of Health and Human Services: Washington, DC, USA, 2010.
2. World Health Organization. Global Status Report on Alcohol and Health; World Health Organization: Geneva, Switzerland, 2011.
3. Bouchery, E.E.; Harwood, H.J.; Sacks, J.J.; Simon, C.J.; Brewer, R.D. Economic costs of excessive alcohol consumption in the U.S., 2006. Am. J. Prev. Med. 2011, 41, 516–524.
4. Grant, B.F.; Dufour, M.C.; Harford, T.C. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 1988, 8, 12–25.
5. Singal, A.K.; Guturu, P.; Hmoud, B.; Kuo, Y.F.; Salameh, H.; Wiesner, R.H. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation 2013, 95, 755–760.
6. Bergheim, I.; McClain, C.J.; Arteel, G.E. Treatment of alcoholic liver disease. Dig. Dis. 2005, 23, 275–284.
7. La Vecchia, C.; Negri, E.; D’Avanzo, B.; Boyle, P.; Franceschi, S. Medical history and primary liver cancer. Cancer Res. 1990, 50, 6274–6277.
8. Venook, A.P.; Papandreou, C.; Furuse, J.; de Guevara, L.L. The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist 2010, 15, 5–13.
9. Gogel, B.M.; Goldstein, R.M.; Kuhn, J.A.; McCarty, T.M.; Donahoe, A.; Glastad, K. Diagnostic evaluation of hepatocellular carcinoma in a cirrhotic liver. Oncology (Williston Park) 2000, 14, 15–20.
10. Jong, G.M.; Hsiue, T.R.; Chen, C.R.; Chang, H.Y.; Chen, C.W. Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics. Chest 1995, 107, 214–217.
11. Perlino, C.A.; Rimland, D. Alcoholism, leukopenia, and pneumococcal sepsis. Am. Rev. Respir. Dis. 1985, 132, 757–760.
12. Cook, R.T. Alcohol abuse, alcoholism, and damage to the immune system—A review. Alcohol. Clin. Exp. Res. 1998, 22, 1927–1942.
13. Davis, C.C.; Mellencamp, M.A.; Preheim, L.C. A model of pneumococcal pneumonia in chronically intoxicated rats. J. Infect. Dis. 1991, 163, 799–805.
14. Lister, P.D.; Gentry, M.J.; Preheim, L.C. Ethanol impairs neutrophil chemotaxis in vitro but not adherence or recruitment to lungs of rats with experimental pneumococcal pneumonia. J. Infect. Dis. 1993, 167, 1131–1137.
15. Nelson, S.; Shellito, J.; Mason, C.; Summer, W.R. Alcohol and bacterial pneumonia. Alcohol Health Res. World. 1992, 16, 73–80.
16. Kershaw, C.D. Alcoholic Lung Disease. Alcohol. Res. Health 2008, 31, 66–75.
17. Fuxench-Lopez, Z.; Ramirez-Ronda, C.H. Pharyngeal flora in ambulatory alcoholic patients: Prevalence of gram-negative bacilli. Arch. Intern. Med. 1978, 138, 1815–1816.
18. Wyatt, T.A.; Gentry-Nielsen, M.J.; Pavlik, J.A.; Sisson, J.H. Desensitization of PKA-stimulated ciliary beat frequency in an ethanol-fed rat model of cigarette smoke exposure. Alcohol. Clin. Exp. Res. 2004, 28, 998–1004.
19. Zhang, P.; Bagby, G.J.; Xie, M.; Stoltz, D.A.; Summer, W.R.; Nelson, S. Acute ethanol intoxication inhibits neutrophil beta2-integrin expression in rats during endotoxemia. Alcohol. Clin. Exp. Res. 1998, 22, 135–141.
20. Bautista, A.P.; Elliott, K.E. Acute ethanol intoxication regulates f-met-leu-phe-induced chemotaxis and superoxide release by neutrophils and Kupffer cells through modulation of the formyl peptide receptor in the rat. Life Sci. 1994, 54, 721–730.
21. MacGregor, R.R. In vivo neutrophil delivery in men with alcoholic cirrhosis is normal despite depressed in vitro chemotaxis. Alcohol. Clin. Exp. Res. 1990, 14, 195–199.
22. Patel, M.; Keshavarzian, A.; Kottapalli, V.; Badie, B.; Winship, D.; Fields, J.Z. Human neutrophil functions are inhibited in vitro by clinically relevant ethanol concentrations. Alcohol. Clin. Exp. Res. 1996, 20, 275–283.
23. Moss, M.; Bucher, B.; Moore, F.A.; Moore, E.E.; Parsons, P.E. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA 1996, 275, 50–54.
24. Ranieri, V.M.; Rubenfeld, G.D.; Thompson, B.T.; Ferguson, N.D.; Caldwell, E.; Fan, E.; Camporota, L.; Slutsky, A.S. Acute respiratory distress syndrome: The Berlin Definition. J. Am. Med. Assoc. 2012, 307, 2526–2533.
25. Moss, M.; Burnham, E.L. Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction. Crit. Care Med.2003, 31, S207–S212.
26. Mitchell, P.O.; Jensen, J.S.; Ritzenthaler, J.D.; Roman, J.; Pelaez, A.; Guidot, D.M. Alcohol primes the airway for increased interleukin-13 signaling. Alcohol. Clin. Exp. Res. 2009, 33, 505–513.
27. Joshi, P.C.; Applewhite, L.; Ritzenthaler, J.D.; Roman, J.; Fernandez, A.L.; Eaton, D.C.; Brown, L.A.; Guidot, D.M. Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage. J. Immunol. 2005, 175, 6837–6845.
28. Roman, J.; Ritzenthaler, J.D.; Bechara, R.; Brown, L.A.; Guidot, D. Ethanol stimulates the expression of fibronectin in lung fibroblasts via kinase-dependent signals that activate CREB. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 288, L975–L987.
29. Lois, M.; Brown, L.A.; Moss, I.M.; Roman, J.; Guidot, D.M. Ethanol ingestion increases activation of matrix metalloproteinases in rat lungs during acute endotoxemia. Am. J. Respir. Crit. Care Med. 1999, 160, 1354–1360.
30. Holguin, F.; Moss, I.; Brown, L.A.; Guidot, D.M. Chronic ethanol ingestion impairs alveolar type II cell glutathione homeostasis and function and predisposes to endotoxin-mediated acute edematous lung injury in rats. J. Clin. Investig. 1998, 101, 761–768.
31. Otis, J.S.; Brown, L.A.; Guidot, D.M. Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats. Muscle Nerve 2007, 36, 842–848.
32. Guidot, D.M.; Roman, J. Chronic ethanol ingestion increases susceptibility to acute lung injury: Role of oxidative stress and tissue remodeling. Chest 2002, 122, 309S–314S.
33. Powell, W.J., Jr.; Klatskin, G. Duration of survival in patients with Laennec’s cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am. J. Med. 1968, 44, 406–420.
34. Moss, M.; Guidot, D.M.; Wong-Lambertina, M.; Ten Hoor, T.; Perez, R.L.; Brown, L.A. The effects of chronic alcohol abuse on pulmonary glutathione homeostasis. Am. J. Respir. Crit. Care Med. 2000, 161, 414–419.
35. Arteel, G.E. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003, 124, 778–790.
36. Deaciuc, I.V.; Nikolova-Karakashian, M.; Fortunato, F.; Lee, E.Y.; Hill, D.B.; McClain, C.J. Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity. Alcohol. Clin. Exp. Res. 2000, 24, 1557–1565.
37. Beier, J.I.; Luyendyk, J.P.; Guo, L.; von Montfort, C.; Staunton, D.E.; Arteel, G.E. Fibrin accumulation plays a critical role in the sensitization to lipopolysaccharide-induced liver injury caused by ethanol in mice. Hepatology 2009, 49, 1545–1553.
38. Ontko, J.A. Effects of ethanol on the metabolism of free fatty acids in isolated liver cells. J. Lipid Res. 1973, 14, 78–86.
39. Lieber, C.S. Metabolic effects of acetaldehyde. Biochem. Soc. Trans. 1988, 16, 241–247.
40. Klassen, L.W.; Tuma, D.; Sorrell, M.F. Immune mechanisms of alcohol-induced liver disease. Hepatology 1995, 22, 355–357.
41. Niemela, O. Distribution of ethanol-induced protein adducts in vivo: Relationship to tissue injury. Free Rad. Biolol. Med. 2001, 31, 1533–1538.
42. Thiele, G.M.; Worrall, S.; Tuma, D.J.; Klassen, L.W.; Wyatt, T.A.; Nagata, N. The chemistry and biological effects of malondialdehyde-acetaldehyde adducts. Alcohol. Clin. Exp. Res. 2001, 25, 218S–224S.
43. Visvanathan, K.; Crum, R.M.; Strickland, P.T.; You, X.; Ruczinski, I.; Berndt, S.I.; Alberg, A.J.; Hoffman, S.C.; Comstock, G.W.; Bell, D.A., et al. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcohol. Clin. Exp. Res. 2007, 31, 467–476.
44. Eriksson, C.J. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol. Clin. Exp. Res. 2001, 25, 15S–32S.
45. Lieber, C.S. Ethanol metabolism, cirrhosis and alcoholism. Clin. Chim. Acta 1997, 257, 59–84.
46. Bardag-Gorce, F.; Yuan, Q.X.; Li, J.; French, B.A.; Fang, C.; Ingelman-Sundberg, M.; French, S.W. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem. Biophys. Res. Commun. 2000, 279, 23–29.
47. Ekstrom, G.; Ingelman-Sundberg, M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem. Pharmacol. 1989, 38, 1313–1319.
48. Enomoto, N.; Ikejima, K.; Bradford, B.U.; Rivera, C.A.; Kono, H.; Brenner, D.A.; Thurman, R.G. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 1998, 115, 443–451.
49. Wheeler, M.D.; Thurman, R.G. Up-regulation of CD14 in liver caused by acute ethanol involves oxidant-dependent AP-1 pathway. J. Biol. Chem.2003, 278, 8435–8441.
50. Beutler, B. Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol. Rev. 2009, 227, 248–263.
51. Pruett, S.B.; Zheng, Q.; Fan, R.; Matthews, K.; Schwab, C. Ethanol suppresses cytokine responses induced through Toll-like receptors as well as innate resistance to Escherichia coli in a mouse model for binge drinking. Alcohol 2004, 33, 147–155.
52. Goral, J.; Kovacs, E.J. In vivo ethanol exposure down-regulates TLR2-, TLR4-, and TLR9-mediated macrophage inflammatory response by limiting p38 and ERK1/2 activation. J. Immunol. 2005, 174, 456–463.
53. Spencer, S.; Rubin, K.P.; Lieber, C.S. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation. Dig. Dis. Sci.1983, 28, 585–589.
54. Bigatello, L.M.; Broitman, S.A.; Fattori, L.; di Paoli, M.; Pontello, M.; Bevilacqua, G.; Nespoli, A. Endotoxemia, encephalopathy, and mortality in cirrhotic patients. Am. J. Gastroenterol. 1987, 82, 11–15.
55. Deaciuc, I.V.; Fortunato, F.; D’Souza, N.B.; Hill, D.B.; Schmidt, J.; Lee, E.Y.; McClain, C.J. Modulation of caspase-3 activity and Fas ligand mRNA expression in rat liver cells in vivo by alcohol and lipopolysaccharide. Alcohol. Clin. Exp. Res. 1999, 23, 349–356.
56. McClain, C.J.; Cohen, D.A. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989, 9, 349–351.
57. Hill, D.B.; Marsano, L.; Cohen, D.; Allen, J.; Shedlofsky, S.; McClain, C.J. Increased plasma interleukin-6 concentrations in alcoholic hepatitis. J. Lab. Clin. Med. 1992, 119, 547–552.
58. Hill, D.B.; Marsano, L.S.; McClain, C.J. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993, 18, 576–580.
59. Devalaraja, M.N.; McClain, C.J.; Barve, S.; Vaddi, K.; Hill, D.B. Increased monocyte MCP-1 production in acute alcoholic hepatitis. Cytokine 1999, 11, 875–881.
60. Fisher, N.C.; Neil, D.A.; Williams, A.; Adams, D.H. Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease. Gut 1999, 45, 416–420.
61. Colell, A.; Garcia-Ruiz, C.; Miranda, M.; Ardite, E.; Mari, M.; Morales, A.; Corrales, F.; Kaplowitz, N.; Fernandez-Checa, J.C. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998, 115, 1541–1551.
62. Liu, H.; Jones, B.E.; Bradham, C.; Czaja, M.J. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 282, G257–G266.
63. Di Luzio, N.R. A mechanism of the acute ethanol-induced fatty liver and the modification of liver injury by antioxidants. Lab. Investig. 1966, 15, 50–63.
64. Shaw, S.; Jayatilleke, E.; Ross, W.A.; Gordon, E.R.; Lieber, S. Ethanol-induced lipid peroxidation: Potentiation by long-term alcohol feeding and attenuation by methionine. J. Lab. Clin. Med. 1981, 98, 417–424.
65. Patek, A.J., Jr. Alcohol, malnutrition, and alcoholic cirrhosis. Am. J. Clin. Nutr. 1979, 32, 1304–1312.
66. Bujanda, L. The effects of alcohol consumption upon the gastrointestinal tract. Am. J. Gastroenterol. 2000, 95, 3374–3382.
67. Lieber, C.S. ALCOHOL: Its metabolism and interaction with nutrients. Annu. Rev. Nutr.2000, 20, 395–430.
68. Kono, H.; Arteel, G.E.; Rusyn, I.; Sies, H.; Thurman, R.G. Ebselen prevents early alcohol-induced liver injury in rats. Free Radic. Biolol. Med. 2001, 30, 403–411.
69. Kono, H.; Rusyn, I.; Uesugi, T.; Yamashina, S.; Connor, H.D.; Dikalova, A.; Mason, R.P.; Thurman, R.G. Diphenyleneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280, G1005–G1012.
70. Kono, H.; Rusyn, I.; Connor, H.; Mason, R.P.; Thurman, R.G. Allopurinol prevents early alcohol-induced liver injury in rats. J. Pharmacol. Exp. Ther. 2000, 293, 296–303.
71. Boveris, A.; Chance, B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973, 134, 707–716.
72. Bailey, S.M.; Pietsch, E.C.; Cunningham, C.C. Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III. Free Radic. Biol. Med. 1999, 27, 891–900.
73. Fernandez-Checa, J.C.; Kaplowitz, N.; Garcia-Ruiz, C.; Colell, A.; Miranda, M.; Mari, M.; Ardite, E.; Morales, A. GSH transport in mitochondria: Defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol. 1997, 273, G7–G17.
74. Kono, H.; Uesugi, T.; Froh, M.; Rusyn, I.; Bradford, B.U.; Thurman, R.G. ICAM-1 is involved in the mechanism of alcohol-induced liver injury: Studies with knockout mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280, G1289–G1295.
75. Schuppan, D.; Ruehl, M.; Somasundaram, R.; Hahn, E.G. Matrix as a modulator of hepatic fibrogenesis. Semin. Liver Dis. 2001, 21, 351–372.
76. Cassiman, D.; Libbrecht, L.; Desmet, V.; Denef, C.; Roskams, T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 2002, 36, 200–209.
77. Zeisberg, M.; Yang, C.; Martino, M.; Duncan, M.B.; Rieder, F.; Tanjore, H.; Kalluri, R. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 2007, 282, 23337–23347.
78. Robertson, H.; Kirby, J.A.; Yip, W.W.; Jones, D.E.; Burt, A.D. Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis. Hepatology 2007, 45, 977–981.
79. Omenetti, A.; Porrello, A.; Jung, Y.; Yang, L.; Popov, Y.; Choi, S.S.; Witek, R.P.; Alpini, G.; Venter, J.; Vandongen, H.M., et al.Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J. Clin. Investig. 2008, 118, 3331–3342.
80. Poynard, T.; McHutchison, J.; Manns, M.; Trepo, C.; Lindsay, K.; Goodman, Z.; Ling, M.H.; Albrecht, J. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002, 122, 1303–1313.
81. Holdsworth, S.R.; Thomson, N.M.; Glasgow, E.F.; Atkins, R.C. The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: Studies using glomerular culture and electronmicroscopy. Clin. Exp. Immunol. 1979, 37, 38–43.
82. Loike, J.D.; el Khoury, J.; Cao, L.; Richards, C.P.; Rascoff, H.; Mandeville, J.T.; Maxfield, F.R.; Silverstein, S.C. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine. J. Exp. Med. 1995, 181, 1763–1772.
83. Ganey, P.E.; Luyendyk, J.P.; Maddox, J.F.; Roth, R.A. Adverse hepatic drug reactions: Inflammatory episodes as consequence and contributor. Chem. Biol. Interact. 2004, 150, 35–51.
84. Pearson, J.M.; Schultze, A.E.; Schwartz, K.A.; Scott, M.A.; Davis, J.M.; Roth, R.A. The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat. J. Pharmacol. Exp. Ther. 1996, 278, 378–383.
85. Hodivala-Dilke, K.M.; Reynolds, A.R.; Reynolds, L.E. Integrins in angiogenesis: Multitalented molecules in a balancing act. Cell Tissue Res. 2003, 314, 131–144.
86. Zhou, H.F.; Chan, H.W.; Wickline, S.A.; Lanza, G.M.; Pham, C.T. Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J. 2009, 23, 2978–2985.
87. Manautou, J.E.; Buss, N.J.; Carlson, G.P. Oxidative and non-oxidative metabolism of ethanol by the rabbit lung. Toxicol. Lett. 1992, 62, 93–99.
88. George, S.C.; Hlastala, M.P.; Souders, J.E.; Babb, A.L. Gas exchange in the airways. J. Aerosol. Med.1996, 9, 25–33.
89. Hlastala, M.P. The alcohol breath test—A review. J. Appl. Physiol.1998, 84, 401–408.
90. Masoro, E.J.; Abramovitch, H.; Birchard, J.R. Metabolism of C14 ethanol by surviving rat tissues. Am. J. Physiol. 1953, 173, 37–40.
91. Freund, G.; O’Hollaren, P. Acetaldehyde concentrations in alveolar air following a standard dose of ethanol in man. J. Lipid Res. 1965, 6, 471–477.
92. Karkoulias, K.; Tsitsaras, H.; Patouchas, D.; Sampsonas, F.; Likouras, D.; Kaparianos, A.; Spiropoulos, K. The alcoholic lung disease: Historical background and clinical features. Medicina (Kaunas) 2008, 44, 651–664.
93. Majno, G.J. Cells, Tissues and Disease, 2nd ed.; Oxford University Press: Oxford, UK, 2004.
94. Kumar, V.C.; Robbins, S.L. Robbins Basic Pathology, 7th ed.; Oxford University Press: Oxford, UK, 2003.
95. Omidvari, K.; Casey, R.; Nelson, S.; Olariu, R.; Shellito, J.E. Alveolar macrophage release of tumor necrosis factor-alpha in chronic alcoholics without liver disease. Alcohol. Clin. Exp. Res. 1998, 22, 567–572.
96. Greenberg, S.S.; Xie, J.; Wang, Y.; Kolls, J.; Malinski, T.; Summer, W.R.; Nelson, S. Ethanol suppresses LPS-induced mRNA for nitric oxide synthase II in alveolar macrophages in vivo and in vitro. Alcohol 1994, 11, 539–547.
97. Standiford, T.J.; Danforth, J.M. Ethanol feeding inhibits proinflammatory cytokine expression from murine alveolar macrophages ex vivo. Alcohol. Clin. Exp. Res. 1997, 21, 1212–1217.
98. Crews, F.T.; Bechara, R.; Brown, L.A.; Guidot, D.M.; Mandrekar, P.; Oak, S.; Qin, L.; Szabo, G.; Wheeler, M.; Zou, J. Cytokines and alcohol. Alcohol. Clin. Exp. Res. 2006, 30, 720–730.
99. Trapnell, B.C.; Whitsett, J.A. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu. Rev. Physiol. 2002, 64, 775–802.
100. Pelaez, A.; Bechara, R.I.; Joshi, P.C.; Brown, L.A.; Guidot, D.M. Granulocyte/macrophage colony-stimulating factor treatment improves alveolar epithelial barrier function in alcoholic rat lung. Am. J. Physiol.2004, 286, L106–L111.
101. Joshi, P.C.; Mehta, A.; Jabber, W.S.; Fan, X.; Guidot, D.M. Zinc deficiency mediates alcohol-induced alveolar epithelial and macrophage dysfunction in rats. Am. J. Physiol. Cell Mol. Biol. 2009, 41, 207–216.
102. Mehta, A.J.; Joshi, P.C.; Fan, X.; Brown, L.A.; Ritzenthaler, J.D.; Roman, J.; Guidot, D.M. Zinc supplementation restores PU.1 and Nrf2 nuclear binding in alveolar macrophages and improves redox balance and bacterial clearance in the lungs of alcohol-fed rats. Alcohol. Clin. Exp. Res. 2011, 35, 1519–1528.
103. Tacke, F.; Kurts, C. Infiltrating monocytes versus resident Kupffer cells: Do alternatively activated macrophages need to be targeted alternatively? Hepatology 2011, 54, 2267–2270.
104. De Rycke, L.; Baeten, D.; Foell, D.; Kruithof, E.; Veys, E.M.; Roth, J.; de, Keyser, F. Differential expression and response to anti-TNFalpha treatment of infiltrating versus resident tissue macrophage subsets in autoimmune arthritis. J. Pathol. 2005, 206, 17–27.
105. Astry, C.L.; Warr, G.A.; Jakab, G.J. Impairment of polymorphonuclear leukocyte immigration as a mechanism of alcohol-induced suppression of pulmonary antibacterial defenses. Am. Rev. Respirat. Dis. 1983, 128, 113–117.
106. Balamayooran, G.; Batra, S.; Fessler, M.B.; Happel, K.I.; Jeyaseelan, S. Mechanisms of neutrophil accumulation in the lungs against bacteria. Am. J. Respirat. Cell Mol. Biol. 2010, 43, 5–16.
107. Zhao, X.J.; Marrero, L.; Song, K.; Oliver, P.; Chin, S.Y.; Simon, H.; Schurr, J.R.; Zhang, Z.; Thoppil, D.; Lee, S., et al.Acute alcohol inhibits TNF-alpha processing in human monocytes by inhibiting TNF/TNF-alpha-converting enzyme interactions in the cell membrane. J. Immunol. 2003, 170, 2923–2931.
108. Ware, L.B.; Matthay, M.A. The acute respiratory distress syndrome. N. Engl. J. Med.2000, 342, 1334–1349.
109. Fernandez, A.L.; Koval, M.; Fan, X.; Guidot, D.M. Chronic alcohol ingestion alters claudin expression in the alveolar epithelium of rats. Alcohol 2007, 41, 371–379.
110. Bechara, R.I.; Brown, L.A.; Roman, J.; Joshi, P.C.; Guidot, D.M. Transforming growth factor beta1 expression and activation is increased in the alcoholic rat lung. Am. J. Respir. Crit. Care Med.2004, 170, 188–194.
111. Bechara, R.I.; Pelaez, A.; Palacio, A.; Joshi, P.C.; Hart, C.M.; Brown, L.A.; Raynor, R.; Guidot, D.M. Angiotensin II mediates glutathione depletion, transforming growth factor-beta1 expression, and epithelial barrier dysfunction in the alcoholic rat lung. Am. J. Physiol. 2005, 289, L363–L370.
112. Sheppard, D. Modulation of acute lung injury by integrins. Proc. Am. Thorac. Soc. 2012, 9, 126–129.
113. Pittet, J.F.; Griffiths, M.J.; Geiser, T.; Kaminski, N.; Dalton, S.L.; Huang, X.; Brown, L.A.; Gotwals, P.J.; Koteliansky, V.E.; Matthay, M.A., et al.TGF-beta is a critical mediator of acute lung injury. J. Clin. Investig. 2001, 107, 1537–1544.
114. Sies H. Ed. Oxidative stress: Introductory remarks. In Oxidative Stress; Academic Press: London, UK, 1985; pp. 1–8.
115. Brown, L.A.; Harris, F.L.; Bechara, R.; Guidot, D.M. Effect of chronic ethanol ingestion on alveolar type II cell: Glutathione and inflammatory mediator-induced apoptosis. Alcohol. Clin. Exp. Res. 2001, 25, 1078–1085.
116. Guidot, D.M.; Modelska, K.; Lois, M.; Jain, L.; Moss, I.M.; Pittet, J.F.; Brown, L.A. Ethanol ingestion via glutathione depletion impairs alveolar epithelial barrier function in rats. Am. J. Physiol.2000, 279, L127–L135.
117. Guidot, D.M.; Brown, L.A. Mitochondrial glutathione replacement restores surfactant synthesis and secretion in alveolar epithelial cells of ethanol-fed rats. Alcohol. Clin. Exp. Res. 2000, 24, 1070–1076.
118. Brown, L.A.; Ping, X.D.; Harris, F.L.; Gauthier, T.W. Glutathione availability modulates alveolar macrophage function in the chronic ethanol-fed rat. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 292, L824–L832.
119. Brown, L.A.; Harris, F.L.; Ping, X.D.; Gauthier, T.W. Chronic ethanol ingestion and the risk of acute lung injury: A role for glutathione availability? Alcohol 2004, 33, 191–197.
120. Yeh, M.Y.; Burnham, E.L.; Moss, M.; Brown, L.A. Chronic alcoholism alters systemic and pulmonary glutathione redox status. Am. J. Respir. Crit. Care Med. 2007, 176, 270–276.
121. Brown, D.I.; Griendling, K.K. Nox proteins in signal transduction. Free Radic. Biol. Med. 2009, 47, 1239–1253.
122. Polikandriotis, J.A.; Rupnow, H.L.; Elms, S.C.; Clempus, R.E.; Campbell, D.J.; Sutliff, R.L.; Brown, L.A.; Guidot, D.M.; Hart, C.M. Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung. Am. J. Respir. Cell Mol. Biol. 2006, 34, 314–319.
123. Yeligar, S.M.; Harris, F.L.; Hart, C.M.; Brown, L.A. Ethanol induces oxidative stress in alveolar macrophages via upregulation of NADPH oxidases. J. Immunol. 2012, 188, 3648–3657.
124. Jackson, S.H.; Gallin, J.I.; Holland, S.M. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 1995, 182, 751–758.
125. Rahman, I.; Biswas, S.K.; Kode, A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 2006, 533, 222–239.
126. Bellocq, A.; Azoulay, E.; Marullo, S.; Flahault, A.; Fouqueray, B.; Philippe, C.; Cadranel, J.; Baud, L. Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am. J. Respir. Cell Mol. Biol. 1999, 21, 128–136.
127. Go, Y.M.; Jones, D.P. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation 2005, 111, 2973–2980.
128. Jones, D.P. Redefining oxidative stress. Antioxid. Redox Signal. 2006, 8, 1865–1879.
129. Nkabyo, Y.S.; Go, Y.M.; Ziegler, T.R.; Jones, D.P. Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289, G70–G78.
130. Ramirez, A.; Ramadan, B.; Ritzenthaler, J.D.; Rivera, H.N.; Jones, D.P.; Roman, J. Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta. Am. J. Physiol. Lung Cell Mol. Physiol. 2007, 293, L972–L981.
131. Iyer, S.S.; Ramirez, A.M.; Ritzenthaler, J.D.; Torres-Gonzalez, E.; Roser-Page, S.; Mora, A.L.; Brigham, K.L.; Jones, D.P.; Roman, J.; Rojas, M. Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2009, 296, L37–L45.
132. Iyer, S.S.; Accardi, C.J.; Ziegler, T.R.; Blanco, R.A.; Ritzenthaler, J.D.; Rojas, M.; Roman, J.; Jones, D.P. Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS ONE 2009, 4, e5017.
133. Clark, R.A.; Lanigan, J.M.; DellaPelle, P.; Manseau, E.; Dvorak, H.F.; Colvin, R.B. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J. Investig. Dermatol. 1982, 79, 264–269.
134. Bitterman, P.; Rennard, S.; Adelberg, S.; Crystal, R.G. Role of fibronectin in fibrotic lung disease. A growth factor for human lung fibroblasts. Chest 1983, 83, 96S.
135. Norris, D.A.; Clark, R.A.F.; Swigart, L.M.; Huff, J.C.; Weston, W.M.; Howell, S.E. Fibronectin fragment(s) are chemotactic for human peripheral blood monocytes. J. Immunol. 1982, 129, 1612–1618.
136. Burnham, E.L.; Moss, M.; Ritzenthaler, J.D.; Roman, J. Increased fibronectin expression in lung in the setting of chronic alcohol abuse. Alcohol. Clin. Exp. Res. 2007, 31, 675–683.
137. Brown, L.A.; Ritzenthaler, J.D.; Guidot, D.M.; Roman, J. Alveolar type II cells from ethanol-fed rats produce a fibronectin-enriched extracellular matrix that promotes monocyte activation. Alcohol 2007, 41, 317–324.
138. Koval, M.; Ward, C.; Findley, M.K.; Roser-Page, S.; Helms, M.N.; Roman, J. Extracellular matrix influences alveolar epithelial claudin expression and barrier function. Am. J. Respir. Cell Mol. Biol. 2010, 42, 172–180.
139. Pavlov, M. The anti-toxic function of the liver. Lancet 1893, 2, 1092.
140. Rutenburg, A.M.; Sonnenblick, E.; Koven, I.; Aprahamian, H.A.; Reiner, L.; Fine, J. The role of intestinal bacteria in the development of dietary cirrhosis in rats. J. Exp. Med. 1957, 106, 1–14.
141. Broitman, S.A.; Gottlieb, L.S.; Zamcheck, N. Influence of neomycin and ingested endotoxin in the pathogenesis of choline deficiency cirrhosis in the adult rat. J. Exp. Med.1964, 119, 633–647.
142. Nolan, J.P.; Ali, M.V. Endotoxin and the liver. II Effect of tolerance on carbon tetrachloride induced injury. J. Med. 1973, 4, 28–38.
143. Nolan, J.P.; Leibowitz, A.I. Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin B—An antiendotoxin. Gastroenterology 1978, 75, 445–449.
144. Nolan, J.P. The role of intestinal endotoxin in liver injury: A long and evolving history. Hepatology 2010, 52, 1829–1835.
145. Wilkinson, S.P.; Arroyo, V.; Gazzard, B.G.; Moodie, H.; Williams, R. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure. Lancet 1974, 1, 521–524.
146. Tarao, K.; Moroi, T.; Nagakura, Y.; Ikeuchi, T.; Suyama, T.; Endo, O.; Fukushima, K. Relationship between endotoxaemia and protein concentration of ascites in cirrhotic patients. Gut 1979, 20, 205–210.
147. Bode, C.H.; Kugler, V.; Bode, J.C.H. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 1987, 4, 8–14.
148. Adachi, Y.; Moore, L.E.; Bradford, B.U.; Gao, W.; Thurman, R.G. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995, 108, 218–224.
149. Yin, M.; Bradford, B.U.; Wheeler, M.D.; Uesugi, T.; Froh, M.; Goyert, S.M.; Thurman, R.G. Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol. 2001, 166, 4737–4742.
150. Uesugi, T.; Froh, M.; Arteel, G.E.; Bradford, B.U.; Thurman, R.G. Toll-like receptor 4 is involved in the mechanism of early alcohol- induced liver injury in mice. Hepatology 2001, 34, 101–108.
151. Uesugi, T.; Froh, M.; Arteel, G.E.; Bradford, B.U.; Wheeler, M.D.; Gabele, E.; Isayama, F.; Thurman, R.G. Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J. Immunol. 2002, 168, 2963–2969.
152. Hartmann, P.; Chen, W.C.; Schnabl, B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front. Physiol. 2012, doi:10.3389/fphys.2012.00402.
153. Szabo, G.; Bala, S. Alcoholic liver disease and the gut-liver axis. World J. Gastroenterol. 2010, 16, 1321–1329.
154. Kirpich, I.A.; McClain, C.J. Probiotics in the treatment of the liver diseases. J. Am. Coll Nutr. 2012, 31, 14–23.
155. Khanlou, H.; Souto, H.; Lippmann, M.; Munoz, S.; Rothstein, K.; Ozden, Z. Resolution of adult respiratory distress syndrome after recovery from fulminant hepatic failure. Am. J. Med. Sci. 1999, 317, 134–136.
156. Matuschak, G.M. Lung-liver interactions in sepsis and multiple organ failure syndrome. Clin. Chest. Med. 1996, 17, 83–98.
157. Matuschak, G.M.; Pinsky, M.R.; Klein, E.C.; van Thiel, D.H.; Rinaldo, J.E. Effects of D-galactosamine-induced acute liver injury on mortality and pulmonary responses to Escherichia coli lipopolysaccharide. Modulation by arachidonic acid metabolites. Am. Rev. Respirat. Dis. 1990, 141, 1296–1306.
158. Siore, A.M.; Parker, R.E.; Stecenko, A.A.; Cuppels, C.; McKean, M.; Christman, B.W.; Cruz-Gervis, R.; Brigham, K.L. Endotoxin-induced acute lung injury requires interaction with the liver. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289, L769–L776.
159. Siore, A.M.; Parker, R.E.; Cuppels, C.; Thorn, N.; Hansen, J.M.; Stecenko, A.A.; Brigham, K.L. The role of mitochondrial oxidation in endotoxin-induced liver-dependent swine pulmonary edema. Pulm. Pharmacol. Ther. 2012, 25, 407–412.
160. Matuschak, G.M.; Mattingly, M.E.; Tredway, T.L.; Lechner, A.J. Liver-lung interactions during E. coli endotoxemia. TNF-alpha:leukotriene axis. Am. J. Respir. Crit Care Med. 1994, 149, 41–49.
161. Massey, V.L.; Poole, L.G.; Siow, D.L.; Torres, E.; Warner, N.L.; Schmidt, R.H.; Ritzenthaler, J.D.; Roman, J.; Arteel, G.E. Chronic alcohol exposure enhances lipopolysaccharide-induced lung injury in mice: Potential role of systemic tumor necrosis factor alpha. Alcohol. Clin. Exp. Res. 2015, doi:10.1111/acer.12855.